Ozempic’s most common side effects are gastrointestinal: nausea, vomiting, diarrhea, abdominal pain, and constipation, each affecting at least 5% of people who take it. Most of these are mild and fade within a few weeks, but some people experience more serious complications, and a small percentage stop taking the medication because of stomach-related symptoms.
Why Ozempic Causes Stomach Problems
Ozempic (semaglutide) works by mimicking a hormone your gut naturally releases after you eat. This hormone, GLP-1, signals your brain to reduce appetite and slows the rate at which your stomach empties food into your intestines. The drug amplifies that process significantly, which is why it helps with blood sugar control and weight loss, but it’s also why your digestive system protests, especially early on.
When your stomach holds onto food longer than usual, you feel full faster, but you can also feel nauseated, bloated, or gassy. That delayed emptying is most pronounced in the first few weeks of treatment. After about 16 weeks, the effect on stomach motility tends to diminish as your body adjusts to the medication.
Common Side Effects and How Long They Last
The gastrointestinal side effects hit hardest during two windows: when you first start taking the drug, and each time your dose goes up. Ozempic is prescribed on a gradual schedule for this reason. You begin at a low dose for four weeks, then step up. The majority of nausea, vomiting, and diarrhea reports occur during these dose increases.
For most people, these symptoms are mild and resolve within a few weeks at each dose level. In clinical trials, about 3% to 4% of people on Ozempic stopped taking it because of stomach side effects, compared to less than 1% on placebo. At the higher 2 mg dose, gastrointestinal problems occurred in 34% of patients, versus about 31% at the 1 mg dose. So the side effects are dose-dependent: more medication, more stomach trouble.
Beyond the GI symptoms, some people report headaches, fatigue, and dizziness, particularly during the adjustment period.
Gallbladder Problems
Ozempic and other GLP-1 drugs are linked to acute gallbladder disease, including gallstones and gallbladder inflammation. This has been observed both in clinical trials and in post-marketing reports. Rapid weight loss from any cause increases the risk of gallstones, and the additional effect of slowed digestion may compound that risk. Symptoms to watch for include sudden, intense pain in your upper right abdomen, pain between your shoulder blades, and nausea that feels different from the typical stomach upset of the medication.
Pancreatitis
Inflammation of the pancreas has been reported in people taking Ozempic. Pancreatitis causes severe abdominal pain that often radiates to your back and typically worsens after eating. It can become a medical emergency. If pancreatitis is confirmed, the medication has to be stopped permanently. The risk is uncommon, but it’s one of the more serious complications listed in the drug’s warnings.
Kidney Injury From Dehydration
This is a side effect that catches people off guard because it’s indirect. The nausea, vomiting, and diarrhea that Ozempic causes can lead to significant dehydration, and dehydration can damage your kidneys. The FDA has required updated label warnings specifically about this chain of events. Some reported cases have been severe enough to require dialysis.
The risk is highest when you’re first starting the medication or stepping up to a higher dose, since that’s when GI symptoms peak. Persistent vomiting or diarrhea lasting more than a day or two is the warning sign. Staying well hydrated matters more on this medication than people often realize, particularly during the early weeks.
Gastroparesis and Bowel Obstruction
Because Ozempic slows stomach emptying, a small number of users develop gastroparesis, a condition where the stomach takes far too long to move food through. In one large study, gastroparesis occurred at a rate of about 10 cases per 1,000 semaglutide users, and those on GLP-1 drugs were 3.7 times more likely to develop it compared to people on a different weight-loss medication. Symptoms include feeling full after just a few bites, bloating, nausea that doesn’t resolve, and vomiting undigested food hours after a meal.
Bowel obstruction is rarer but also elevated: GLP-1 users in the same study were 4.2 times more likely to experience it. The FDA added ileus (a type of bowel obstruction where the intestines stop moving food forward) to the drug’s post-marketing adverse reaction list. Severe abdominal pain, inability to pass gas, and vomiting are the hallmark signs.
Thyroid Tumor Risk
Ozempic carries the FDA’s most prominent safety warning, a boxed warning, for thyroid tumors. In animal studies, semaglutide caused thyroid C-cell tumors at doses comparable to what humans take, and the risk increased with higher doses and longer treatment. Whether this translates to humans is still unknown. Because of this uncertainty, Ozempic is off-limits for anyone with a personal or family history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2.
There’s no reliable screening test to catch these tumors early in people taking the drug. Routine thyroid ultrasounds and blood tests for calcitonin haven’t been shown to help with early detection. What you can do is pay attention to symptoms: a lump or mass in your neck, difficulty swallowing, shortness of breath, or persistent hoarseness that doesn’t go away.
Diabetic Eye Complications
For people with type 2 diabetes who already have some degree of diabetic retinopathy, Ozempic may worsen eye problems. In a two-year trial of patients with diabetes and high cardiovascular risk, diabetic retinopathy complications occurred in 3.0% of those on Ozempic versus 1.8% on placebo. The leading theory is that rapid improvements in blood sugar can paradoxically stress the small blood vessels in the retina. This doesn’t mean the drug causes eye disease from scratch, but if you already have retinal damage, the risk of progression is real.
Low Blood Sugar
Ozempic on its own doesn’t typically cause dangerous drops in blood sugar. The risk climbs when it’s combined with other diabetes medications that actively lower glucose, particularly insulin or sulfonylureas. If you’re on one of these combinations, symptoms like shakiness, sweating, confusion, and rapid heartbeat signal blood sugar that’s dropped too low.
Changes in Facial Appearance
The widely discussed “Ozempic face” isn’t a direct pharmacological side effect but rather a consequence of rapid weight loss. When you lose weight quickly, you lose subcutaneous fat from your face and neck, which leads to a gaunt or hollow appearance, sagging skin, and new wrinkles. Rapid weight loss also reduces your skin’s levels of elastin and collagen, the proteins responsible for keeping skin firm and elastic. This mimics accelerated aging.
The faster the weight loss, the more pronounced this effect tends to be. People who push for maximum doses to reach weight goals quickly are more likely to notice it. Slower, steadier weight loss gives skin more time to adapt, though it can’t fully prevent the change in people who lose a significant amount of weight.
Allergic Reactions
Serious allergic reactions to Ozempic, including anaphylaxis and severe swelling of the face or throat, have been reported. These are rare but can be life-threatening. Any signs of a severe allergic reaction, such as difficulty breathing, rapid heartbeat, or significant swelling, require immediate emergency care. People who have had a serious hypersensitivity reaction to semaglutide should not take the drug again.